Encompass Health Corporation $EHC is Leeward Investments LLC MA’s 2nd Largest Position

Leeward Investments LLC MA cut its holdings in Encompass Health Corporation (NYSE:EHC) by 18.8% in the second quarter, HoldingsChannel reports. The firm owned 351,121 shares of the company’s stock after selling 81,236 shares during the quarter. Encompass Health accounts for 2.3% of Leeward Investments LLC MA’s portfolio, making the stock its 2nd largest position. Leeward Investments LLC MA’s holdings in Encompass Health were worth $43,058,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently bought and sold shares of EHC. WPG Advisers LLC purchased a new position in Encompass Health during the first quarter worth $27,000. Mitsubishi UFJ Asset Management Co. Ltd. boosted its stake in Encompass Health by 749.0% during the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 416 shares of the company’s stock worth $42,000 after buying an additional 367 shares during the period. Arlington Trust Co LLC boosted its stake in Encompass Health by 22.9% during the first quarter. Arlington Trust Co LLC now owns 671 shares of the company’s stock worth $68,000 after buying an additional 125 shares during the period. Park Place Capital Corp purchased a new position in Encompass Health during the second quarter worth $72,000. Finally, Caitong International Asset Management Co. Ltd boosted its stake in Encompass Health by 19.0% during the first quarter. Caitong International Asset Management Co. Ltd now owns 720 shares of the company’s stock worth $73,000 after buying an additional 115 shares during the period. 97.25% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other news, EVP Patrick William Tuer sold 1,020 shares of the company’s stock in a transaction dated Wednesday, August 27th. The shares were sold at an average price of $123.59, for a total transaction of $126,061.80. Following the transaction, the executive vice president owned 18,846 shares in the company, valued at $2,329,177.14. This represents a 5.13% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. 2.00% of the stock is currently owned by company insiders.

Encompass Health Stock Performance

EHC stock opened at $126.23 on Friday. The company has a market capitalization of $12.71 billion, a P/E ratio of 24.70, a PEG ratio of 2.21 and a beta of 0.93. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.06 and a quick ratio of 1.06. The business has a 50-day moving average price of $124.23 and a 200 day moving average price of $118.20. Encompass Health Corporation has a 1-year low of $87.85 and a 1-year high of $127.99.

Encompass Health (NYSE:EHC) last announced its earnings results on Wednesday, March 16th. The company reported $0.93 EPS for the quarter. The business had revenue of $136.30 million during the quarter. Encompass Health had a net margin of 9.22% and a return on equity of 17.83%. Encompass Health has set its FY22 guidance at $3.83-$4.19 EPS. As a group, equities research analysts forecast that Encompass Health Corporation will post 4.8 EPS for the current fiscal year.

Encompass Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, January 15th. Shareholders of record on Friday, January 2nd will be issued a $0.19 dividend. The ex-dividend date is Friday, January 2nd. This represents a $0.76 dividend on an annualized basis and a yield of 0.6%. Encompass Health’s payout ratio is currently 14.87%.

Analyst Upgrades and Downgrades

Several research analysts have commented on EHC shares. Zacks Research raised shares of Encompass Health from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, October 21st. UBS Group lifted their price objective on shares of Encompass Health from $140.00 to $150.00 and gave the company a “buy” rating in a report on Thursday, October 2nd. Truist Financial raised their target price on shares of Encompass Health from $135.00 to $140.00 and gave the stock a “buy” rating in a research report on Thursday, August 14th. Bank of America raised their target price on shares of Encompass Health from $145.00 to $160.00 and gave the stock a “buy” rating in a research report on Wednesday, September 10th. Finally, KeyCorp lifted their price objective on Encompass Health from $135.00 to $140.00 and gave the company an “overweight” rating in a report on Tuesday, September 16th. Two equities research analysts have rated the stock with a Strong Buy rating and eight have given a Buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Buy” and an average target price of $139.86.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.